Education
About Us
Working with TipRanks
Follow Us
Biovica International AB Class B (SE:BIOVIC.B)
:BIOVIC.B
BIOVIC.B Stock Chart & Stats
kr0.35
-kr0.04(-2.00%)
At close: 4:00 PM EST
kr0.35
-kr0.04(-2.00%)
Day’s Range― - ―
52-Week Rangekr0.45 - kr2.17
Previous CloseN/A
Volume59.69K
Average Volume (3M)324.11K
Market Cap
kr96.58M
Enterprise Valuekr45.41M
Total Cash (Recent Filing)kr100.66M
Total Debt (Recent Filing)kr3.04M
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Mar 18, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding275,289,060
10 Day Avg. Volume299,971
30 Day Avg. Volume324,106
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.50
Price to Sales (P/S)7.52
P/FCF Ratio-0.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Biovica International AB Class B News
BIOVIC.B FAQ
What was Biovica International AB Class B’s price range in the past 12 months?
Biovica International AB Class B lowest stock price was kr0.45 and its highest was kr2.17 in the past 12 months.
What is Biovica International AB Class B’s market cap?
Biovica International AB Class B’s market cap is kr96.58M.
When is Biovica International AB Class B’s upcoming earnings report date?
Biovica International AB Class B’s upcoming earnings report date is Mar 18, 2026 which is in 80 days.
How were Biovica International AB Class B’s earnings last quarter?
Biovica International AB Class B released its earnings results on Dec 18, 2025. The company reported -kr0.081 earnings per share for the quarter, the consensus estimate of -kr0.081 by kr0.
Is Biovica International AB Class B overvalued?
According to Wall Street analysts Biovica International AB Class B’s price is currently Overvalued.
Does Biovica International AB Class B pay dividends?
Biovica International AB Class B does not currently pay dividends.
What is Biovica International AB Class B’s EPS estimate?
Biovica International AB Class B’s EPS estimate is -0.08.
How many shares outstanding does Biovica International AB Class B have?
Biovica International AB Class B has 275,289,060 shares outstanding.
What happened to Biovica International AB Class B’s price movement after its last earnings report?
Biovica International AB Class B reported an EPS of -kr0.081 in its last earnings report, expectations of -kr0.081. Following the earnings report the stock price went down -34.701%.
Which hedge fund is a major shareholder of Biovica International AB Class B?
Currently, no hedge funds are holding shares in SE:BIOVIC.B
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biovica International AB Class B
Biovica International AB Class B (BIOVIC.B) is a biotechnology company based in Sweden, specializing in the development of diagnostic solutions for cancer. The company focuses on improving the management of cancer treatment through its innovative blood test products that enable the monitoring of treatment efficacy and disease progression. Biovica's core product, DiviTum, is designed to measure the levels of a specific biomarker in the blood, providing valuable information to oncologists and healthcare providers in making informed treatment decisions.
Technical Analysis
Alzinova AB
―
Biosergen AB
―
Nanologica AB
―
Lipigon Pharmaceuticals AB
―
NextCell Pharma AB
―